Matthieu Coutet (Advent France Biotechnology SAS (AFB))

Coutet, Matthieu (Advent France Biotechnology 201704 Managing Partner before Inserm Transfert)

	Organisation	Advent France Biotechnology SAS (AFB)
	Today	AdBio Partners SAS (AFB)
	Group	AdBio Partners (Group)
	Former/major organisation	Inserm Transfert Initiative (ITI)
	Group	France (govt)
	Product	Advent France Biotechnology Seed-Fund I (AFB Seed Fund I)
	Product 2	BIOTECH

Record changed: 2023-12-19

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Matthieu Coutet

[1] AdBio Partners SAS. (12/7/21). "Press Release: Advent France Biotechnology Becomes AdBio Partners". Paris....
[2] Aglaia Therapeutics. (9/27/21). "Press Release: New Startup Aglaia Therapeutics Raises €4M in Seed Funding to Overcome Resistance in Oncology Targeted Therapies". Villejuif....
[3] Advent France Biotechnology SAS. (3/17/21). "Press Release: Advent France Biotechnology Appoints Alejo Chorny, PhD, as Operating Partner and Head of New Spanish Operations". Paris & Barcelona....
[4] DiogenX. (6/16/20). "Press Release: DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund". Marseille....
[5] Yukin Therapeutics SAS. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]